Background Only clinically validated HPV assays can be accepted in cervical cancer
screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 …

For every 100,000 women in the United States, eight new cervical cancer cases and two
deaths are reported as per the most recent (2017) Center of Disease Control and Prevention …

Rebecca B. Perkins, MD, MSc, 1 Richard S. Guido, MD, 2 Philip E. Castle, PhD, 3 David
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …

Objective The 2019 American Society for Colposcopy and Cervical Pathology Risk-Based
Management Consensus Guidelines for the management of cervical cancer screening …

Methods Risk estimates were drawn from a subset of women in the Kaiser Permanente
Northern California screening program, whose residual cervical specimens were HPV typed …

Triage strategies are needed for primary human papillomavirus (HPV)‐based cervical
cancer screening to identify women requiring colposcopy/biopsy. We assessed the …

Cervical cancer is relatively rare in high‐income countries, where organized screening
programs are in place, as well as opportunistic ones. As the human papillomavirus (HPV) …

Background: Recent studies have shown preliminary evidence that vaccination against
human papillomavirus (HPV) could decrease the risk of persistent/recurrent HSIL in women …

This guideline provides evidence-based guidance on the risk-based management of
cervical dysplasia in the colposcopy setting in the context of primary HPV-based screening …

Background Colposcopy diagnosis and directed biopsy are the key components in cervical
cancer screening programs. However, their performance is limited by the requirement for …